BridgeMD
New treatment option for Glaucoma
Official title Evaluation of BRUDYGLAUCO (DHA + Citicoline) in Patients With Glaucoma
ClinicalTrials.gov ID: NCT07322965
What this study is testing
- What it's testing
- This study aims to evaluate the effects of BrudyGlauco, a nutritional supplement containing DHA (docosahexaenoic acid) and citicoline, on visual function in people with glaucoma. Glaucoma is a progressive optic neuropathy that can lead to vision loss.
- Time commitment: about 12 months
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 75
You may be able to join if
- Patients with chronic glaucoma (primary or secondary, open-angle or closed-angle) diagnosed in at least one eye, meeting the following criteria...
- At least 4 reliable visual field (VF) tests before study enrollment.
- Age between 50 and 75 years.
- If both eyes meet the , the eye with the worst Mean Deviation (MD) will be selected as the study eye.
You likely can't join if
- Use of any vitamin or nutraceutical supplement in the month prior to screening.
- Any condition that could alter visual field testing, including: Neurological diseases. Retinal diseases. Advanced cataracts. Treatment with Lyrica...
- Hypersensitivity to acetylsalicylic acid (aspirin) (cross-reactivity risk with citicoline).
- Ocular surgery or laser treatment in the 3 months prior to enrollment or planned during the study.
- Mean Deviation (MD) of the visual field worse than -20 dB or better than -3 dB.
The study team makes the final eligibility decision.
Where it's taking place
- Barcelona, Barcelona, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barcelona, Barcelona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.